JPH01168872A - Formation of hydroxyapatite coating film - Google Patents

Formation of hydroxyapatite coating film

Info

Publication number
JPH01168872A
JPH01168872A JP32772787A JP32772787A JPH01168872A JP H01168872 A JPH01168872 A JP H01168872A JP 32772787 A JP32772787 A JP 32772787A JP 32772787 A JP32772787 A JP 32772787A JP H01168872 A JPH01168872 A JP H01168872A
Authority
JP
Japan
Prior art keywords
hydrosol
film
substrate
hydroxyapatite
coating film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP32772787A
Other languages
Japanese (ja)
Other versions
JP2629761B2 (en
Inventor
Kenji Saida
健二 才田
Shinji Fujiwara
進治 藤原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP62327727A priority Critical patent/JP2629761B2/en
Priority to DE8888312265T priority patent/DE3865421D1/en
Priority to EP88312265A priority patent/EP0322250B1/en
Publication of JPH01168872A publication Critical patent/JPH01168872A/en
Priority to US07/576,166 priority patent/US5030474A/en
Application granted granted Critical
Publication of JP2629761B2 publication Critical patent/JP2629761B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/32Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00796Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite

Abstract

PURPOSE:To easily form a hydroxyapatite coating film having high bonding strength even on a substrate having a complex surface shape by coating the substrate with hydrosol prepd. by mixing an aq. Ca(OH)2 soln. with an aq. phosphoric acid soln. in the presence of protective colloid, drying the hydrosol and making the resulting film insoluble. CONSTITUTION:An aq. Ca(OH)2 soln. is mixed with an aq. phosphoric acid soln. in 1.50-2.0atomic ratio of Ca to P in the presence of protective colloid such as gelatin to prepare hydrosol. A substrate such as a metal or glass substrate is coated with the hydrosol by application, dipping or other conventional method and the hydrosol is dried. The resulting film is made insoluble by calcining under proper conditions or other method to form a hard hydroxyapatite coating film. This coating film having high bonding strength can easily be formed on the substrate having a complex surface shape or a large area at a high rate of film formation.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は基体の表面にヒドロキシアパタイトの皮膜を形
成する方法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for forming a hydroxyapatite film on the surface of a substrate.

〔従来の技術〕[Conventional technology]

ヒドロキシアパタイトは生体適合性に優れ、吸着能も大
きいことから種々の応用の検討がされてきた。特に生体
硬組織のシ換あるいは修復用のインブラント材としての
利用は活発に研究が進められている。インブラント材と
しては生体適合性のほかに生体力学的強度が要求される
。しかしながらヒドロキシアパタイト自体は焼結体にお
いても強度の点で不十分である。したがって金属材料、
セラミックス、ガラス等を基体あるいは芯材としてその
表面にヒドロキシアパタイトの皮膜を形成することが実
用的に最も有望視されている。
Since hydroxyapatite has excellent biocompatibility and high adsorption capacity, various applications have been investigated. In particular, active research is being carried out on its use as an implant material for the replacement or repair of biological hard tissues. Implant materials are required to have biomechanical strength in addition to biocompatibility. However, hydroxyapatite itself is insufficient in strength even in a sintered body. Therefore metallic materials,
The most promising method for practical use is to form a hydroxyapatite film on the surface of a substrate or core material such as ceramics or glass.

ヒドロキシアパタイトの皮膜を形成する方法として、こ
れまで種々の方法が提案されている。たとえば特開昭5
2−82893号公報にはプラズマ溶射法、特開昭58
−109049号公報にはスパッタリング法、特開昭5
9−111753号公報にはPVD、CVD法、特開昭
53−128190号公報には電気泳動法、特開昭53
−118411号公報には塗布法がそれぞれ開示されて
いる。
Various methods have been proposed so far for forming hydroxyapatite films. For example, JP-A-5
No. 2-82893 describes a plasma spraying method,
-109049 publication describes the sputtering method,
9-111753 discloses PVD and CVD methods, JP-A-53-128190 discloses electrophoresis method, JP-A-53-128190 describes
JP-A-118411 discloses each coating method.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

ところが、プラズマ溶射法、スパッタリング法、CVD
法、PVD法においては多孔体の内部など複雑な形状を
した基体表面には皮膜の形成が困難であり、電気泳動法
においては基体が非導電性のものには皮膜を形成できな
いという問題点を有している。塗布法は操作も簡便であ
り、前記特開昭53−118411号公報には、アパタ
イトの微粉末を水に懸濁させ、この懸濁液を基体の表面
に塗布し焼成する方法が開示されているが、微粉末をよ
り細かい粒子にすることが一般に難しく凝集粒が存在し
易いこと並びに分散している粒子の大きさが一般に0.
1μm以上であることなどのために基体表面へのアパタ
イトの付着強度が弱(、剥離し易いという問題点を有し
ている。
However, plasma spraying, sputtering, CVD
In the method and PVD method, it is difficult to form a film on the surface of a substrate with a complex shape, such as inside a porous body, and in the electrophoresis method, it is difficult to form a film on a substrate that is non-conductive. have. The coating method is easy to operate, and JP-A-53-118411 discloses a method in which fine powder of apatite is suspended in water, and this suspension is coated on the surface of a substrate and fired. However, it is generally difficult to make fine powder into finer particles, agglomerated particles are likely to exist, and the size of the dispersed particles is generally 0.
Because the thickness is 1 μm or more, the adhesion strength of apatite to the substrate surface is weak (and it is easily peeled off).

c問題点を解決するための手段〕 かかる事情に鑑み本発明者らは塗布法により付着強度の
高い皮膜を形成するためには皮膜厚をクラックの発生し
ない1〜2μm以下にすること、凝集のない微粒子を分
散した状態で塗布することが重要であるという構想の下
に鋭意検討した結果、ヒドロゾルを使用することにより
良好なヒドロキシアパタイトの皮膜が形成できることを
見出し本発明を完成するに至った。
Measures for Solving Problems] In view of the above circumstances, the present inventors have determined that in order to form a film with high adhesion strength by the coating method, the film thickness should be 1 to 2 μm or less without cracking, and the film should be resistant to agglomeration. As a result of intensive study based on the idea that it is important to apply fine particles in a dispersed state, the present invention was completed by discovering that a good hydroxyapatite film could be formed by using a hydrosol.

すなわち本発明は保護コロイドの存在下に水酸化カルシ
ウム水溶液とリン酸水溶液をCa/P=1.50〜2.
0(原子比)の割合で混合し調整したヒドロゾルを基体
に被覆した後、乾燥し不溶化処理することを特徴とする
ヒドロキシアパタイト皮膜の形成方法を提供するもので
ある。
That is, in the present invention, a calcium hydroxide aqueous solution and a phosphoric acid aqueous solution are mixed with Ca/P=1.50 to 2.0 in the presence of a protective colloid.
The present invention provides a method for forming a hydroxyapatite film, which comprises coating a substrate with a hydrosol mixed and adjusted at a ratio of 0 (atomic ratio), followed by drying and insolubilization treatment.

以下本発明の詳細な説明する。The present invention will be explained in detail below.

ここにヒドロゾルとは水を分散媒とするコロイドを称す
るもので乳濁液や懸濁液に比較して分散している粒子が
小さいものである。一般にコロイド粒子の大きさは0.
1〜0.001μmである。
Hydrosol herein refers to a colloid that uses water as a dispersion medium, and has smaller dispersed particles compared to emulsions and suspensions. Generally, the size of colloid particles is 0.
It is 1 to 0.001 μm.

ヒドロキシアパタイトのヒドロゾルの一般的な製法につ
いて次の文献、ダメリンス ハンドプソフ デル アン
オーガニシェ ヘミ−(GmelinsHandbuc
h der Anorganischen Che+w
ie )第28をB−3号、1158〜1159 (1
961)に以下の3つの方法が開示されている。
Regarding the general preparation method of hydroxyapatite hydrosol, please refer to the following document:
h der Anorganischen Che+w
ie) No. 28 to B-3, 1158-1159 (1
961) discloses the following three methods.

■リン酸水溶液と水酸化カルシウム水溶液との混合によ
り生成した沈澱を母液と共に撹拌してヒドロキシアパタ
イトのヒドロゾルを製造する。
(2) A precipitate formed by mixing an aqueous phosphoric acid solution and an aqueous calcium hydroxide solution is stirred with the mother liquor to produce a hydrosol of hydroxyapatite.

■リン酸塩水溶液とカルシウム塩水溶液をCa/P=1
.50の割合で混合して生成した第三リン酸カルシウム
の沈澱物をo、ooos〜0.0016Nの濃度で複分
解することによりヒドロキシアパタイトのヒドロゾルを
製造する。
■ Phosphate aqueous solution and calcium salt aqueous solution Ca/P=1
.. A hydrosol of hydroxyapatite is produced by double decomposing a precipitate of tricalcium phosphate produced by mixing at a ratio of 50% to 0.0016N at a concentration of o,oos to 0.0016N.

■ゼラチンの存在下に塩化カルシウム溶液にリン酸三ナ
トリウム溶液を加えたときに生成するリン酸カルシウム
よりヒドロキシアパタイトのヒドロゾルを製造する。た
だし、この際リン酸カルシウムとゼラチンの濃度に依存
する。
■Produce a hydrosol of hydroxyapatite from calcium phosphate, which is produced when a trisodium phosphate solution is added to a calcium chloride solution in the presence of gelatin. However, this depends on the concentrations of calcium phosphate and gelatin.

しかるに本発明者らの実験によればゼラチンなどの保護
コロイドを添加せずに生成させた沈澱物は撹拌を続けて
もゾル化することなく上記■、■の方法は再現すること
ができなかった。また■の方法はヒドロゾルを生成する
が塩化ナトリウムが副生じ、塩化ナトリウムの結晶が大
きいためにこのヒドロゾルを基体等に被覆した場合、皮
膜性状に悪影響を及ぼすことになり好ましくない。
However, according to experiments conducted by the present inventors, the precipitate produced without the addition of a protective colloid such as gelatin did not turn into a sol even with continued stirring, making it impossible to reproduce the above methods ① and ②. . In addition, although the method (2) produces a hydrosol, sodium chloride is produced as a by-product, and since the crystals of sodium chloride are large, when this hydrosol is coated on a substrate, etc., it adversely affects the properties of the film, which is not preferable.

本発明におけるヒドロゾルは保護コロイドの存在下に水
酸化カルシウム水溶液とリン酸水溶液をCa/P=1.
50〜2.0(以下原子比を表わす)の割合で混合して
調整される。特にCa/Pの割合は1.50−1.67
の範囲が好ましい。
The hydrosol in the present invention is prepared by mixing a calcium hydroxide aqueous solution and a phosphoric acid aqueous solution in the presence of a protective colloid with Ca/P=1.
They are mixed and adjusted at a ratio of 50 to 2.0 (hereinafter referred to as atomic ratio). Especially the Ca/P ratio is 1.50-1.67
A range of is preferred.

Ca/P=1.50未満の場合は第ニリン酸カルシウム
が生成し、ヒドロキシアパタイトが生成せず、2.0を
超えると水酸化カルシウムの残留が過大となり、ヒドロ
キシアパタイトの生成割合が城少し好ましくない。
When Ca/P is less than 1.50, calcium diphosphate is produced and hydroxyapatite is not produced, and when it exceeds 2.0, calcium hydroxide remains too much and the proportion of hydroxyapatite produced is slightly unfavorable. .

Ca/P=1.50〜1.67の範囲で水酸化カルシウ
ム水溶液とリン酸水溶液を混合した場合、母液のpHは
最終的には6〜8に推移する。一方、Ca/P=1.6
7を超えると未反応の水酸化カルシウムが母液中に残留
することになり、反応終了後も母液のpHは8〜11と
なる。この場合は必要に応じて酸で中性化してもよい。
When a calcium hydroxide aqueous solution and a phosphoric acid aqueous solution are mixed in the range of Ca/P=1.50 to 1.67, the pH of the mother liquor ultimately changes to 6 to 8. On the other hand, Ca/P=1.6
If it exceeds 7, unreacted calcium hydroxide will remain in the mother liquor, and the pH of the mother liquor will be 8 to 11 even after the reaction is completed. In this case, it may be neutralized with an acid if necessary.

CaノP=1.50〜1.67の範囲で水酸化カルシウ
ム水溶液とリン酸水溶液を混合すれば反応当初は生成す
るリン酸カルシウムが母液内に留まる。これを撹拌下あ
るいは撹拌せずに保持すると母液中の水酸化カルシウム
が次第に消費され、リン酸カルシウムのCa/Pの値が
増加し母液中のpl(は低下する。
If an aqueous calcium hydroxide solution and an aqueous phosphoric acid solution are mixed with Ca no P in the range of 1.50 to 1.67, the calcium phosphate produced remains in the mother liquor at the beginning of the reaction. If this is kept under stirring or without stirring, the calcium hydroxide in the mother liquor will be gradually consumed, the Ca/P value of calcium phosphate will increase, and the pl() in the mother liquor will decrease.

pHが6〜8に達したとき、はとんどの水酸化カルシウ
ムは消費され、複分解反応が終結する。この際リン酸カ
ルシウムのCa/Pの割合は原料の混合割合に等しくな
る。さらに母液から回収し風乾後に得られた粉末を粉末
X線回折により分析したところ低結晶のヒドロキシアパ
タイトを示した。
When the pH reaches 6-8, most of the calcium hydroxide is consumed and the metathesis reaction is terminated. At this time, the Ca/P ratio of calcium phosphate is equal to the mixing ratio of the raw materials. Furthermore, analysis of the powder recovered from the mother liquor and air-dried by powder X-ray diffraction revealed that it contained low-crystalline hydroxyapatite.

本発明で使用する水酸化カルシウムは通常の方法で製造
されたものでよく、特に限定されるものではない、また
該水溶液の濃度は水酸化カルシウムの溶解度以下であれ
ば特に限定されるものではないが、生成する皮膜厚みが
薄くなりすぎないように溶解度のおよそ1/100以上
が望ましい。
Calcium hydroxide used in the present invention may be produced by a conventional method and is not particularly limited, and the concentration of the aqueous solution is not particularly limited as long as it is below the solubility of calcium hydroxide. However, it is desirable that the solubility be approximately 1/100 or more so that the thickness of the formed film does not become too thin.

また本発明で使用するリン酸も通常の方法で製造された
ものでよく、特に限定されるものではない、該水溶液中
の濃度も特に限定されるものではないが、水酸化カルシ
ウムの濃度と同水準とした方が望ましい。
Further, the phosphoric acid used in the present invention may be produced by a conventional method and is not particularly limited.The concentration in the aqueous solution is also not particularly limited, but is the same as the concentration of calcium hydroxide. It is preferable to set it as a standard.

本発明で使用する保護コロイドとしてゼラチン、アルブ
ミン、アラビアゴム、プロタルビン酸、リサルビン酸な
ど通常のものが使用されるが、ヒドロキシアパタイトの
皮膜形成後に不溶化処理し昌いものを選べばよい、保護
コロイドは水酸化カルシウム水溶液またはリン酸水溶液
のいずれか一方あるいは両方に溶解することができる。
Common protective colloids used in the present invention include gelatin, albumin, gum arabic, protalbic acid, and resalbic acid. It can be dissolved in either or both of an aqueous calcium hydroxide solution and an aqueous phosphoric acid solution.

保護コロイドの濃度は生成するヒドロキシアパタイトの
重量の0.5〜10倍量を含有することが望ましい、1
0倍量より多い場合は皮膜中のヒドロキシアパタイトの
濃度が希釈されるので連続したヒドロキシアパタイトの
層が形成され難く、0.5倍量より少ない場合は保護コ
ロイドの作用効果が小さくヒドロゾルの形成が難しいの
で好ましくない。
The concentration of the protective colloid is preferably 0.5 to 10 times the weight of the hydroxyapatite to be produced.
If the amount is more than 0 times, the concentration of hydroxyapatite in the film is diluted, making it difficult to form a continuous hydroxyapatite layer, and if the amount is less than 0.5 times, the effect of the protective colloid is small and the formation of hydrosol is inhibited. I don't like it because it's difficult.

次に本発明により得られたヒドロゾルを基体に被覆する
方法としては塗布、噴霧、浸漬等通常の方法が採用でき
る。
Next, as a method for coating a substrate with the hydrosol obtained according to the present invention, conventional methods such as coating, spraying, and dipping can be employed.

用いる基体としては金属、セラミックス、ガラス等いず
れも可能であるが、プラスチック等疎水性のものには適
用し難しいので表面処理をして親水性にしておいた方が
好ましい。
The substrate to be used may be metal, ceramics, glass, etc., but it is difficult to apply this method to hydrophobic materials such as plastics, so it is preferable to surface-treat the surface to make it hydrophilic.

本発明は特に表面がixmな形状をしている基体に適用
することができる。たとえば表面が多孔化されたインブ
ラント材に適用することができる。
The present invention is particularly applicable to substrates whose surfaces have an ixm shape. For example, it can be applied to an implant material whose surface is made porous.

このようなインブラント材としてはチタン合金などの金
属、アルミナなどのセラミックス、バイオガラスなどの
ガラスがある。
Such implant materials include metals such as titanium alloys, ceramics such as alumina, and glasses such as bioglass.

基体に被覆したヒドロゾルは乾燥され、さらに不溶化処
理を施される。
The hydrosol coated on the substrate is dried and further subjected to an insolubilization treatment.

該不溶化はヒドロキシアパタイトの皮膜をより強力なも
のとするために必要な処理である。具体的な不溶化処理
としては架橋剤等の不溶化薬剤、たとえばホルムアルデ
ヒド、グルタルアルデヒド、タンニン酸等を皮膜に塗布
あるいは噴霧することにより安定で強固な皮膜を製造す
る方法、焼成して保護コロイドを除去し、強固な皮膜の
みとする方法がある。不溶化処理として焼成する場合は
焼成残渣が生じない保護コロイドを選択すればよい。
This insolubilization is a necessary treatment to make the hydroxyapatite film stronger. Specific insolubilization treatments include a method of producing a stable and strong film by coating or spraying an insolubilizing agent such as a crosslinking agent, such as formaldehyde, glutaraldehyde, tannic acid, etc. on the film, and a method of manufacturing a stable and strong film by baking to remove the protective colloid. There is a method that uses only a strong film. When firing is performed as an insolubilization treatment, a protective colloid that does not produce a firing residue may be selected.

焼成条件は使用する保護コロイドの焼失温度、基体の耐
熱温度を考慮して決定すればよい、ただしヒドロキシア
パタイトは1200°C以上では熱分解が著しくなるの
でこの温度以下とするのが望ましい。
The firing conditions may be determined by considering the burnout temperature of the protective colloid used and the heat resistance temperature of the substrate. However, since hydroxyapatite undergoes significant thermal decomposition at temperatures above 1200°C, it is desirable to keep the temperature below this temperature.

〔発明の効果〕〔Effect of the invention〕

本発明によれば従来の塗布法よりも皮膜の付着強度が強
く、しかも複雑な表面形状をした基体に対しても容易に
ヒドロキシアパタイトの皮膜を形成することが可能とな
り、さらに大面積の基体にも皮膜を形成でき、成膜速度
が早く安価な方法であり、得られた基体は種々の用途に
使用でき、特にインブラント材、咬着分離材、触媒とし
て有用である。
According to the present invention, the adhesion strength of the film is stronger than that of conventional coating methods, and it is also possible to easily form a hydroxyapatite film even on a substrate with a complicated surface shape. It is a fast and inexpensive method that can form a film, and the obtained substrate can be used for various purposes, and is particularly useful as an implant material, an interlocking separation material, and a catalyst.

(実施例〕 以下本発明を実施例により説明するが、本発明はこれら
に限定されるものではない。
(Examples) The present invention will be described below with reference to Examples, but the present invention is not limited thereto.

なお実施例において用いる%は重量%を表わす。Note that % used in the examples represents weight %.

実施例1 0.055%水酸化カルシウム水溶液500gに精製ゼ
ラチン1.0gを溶解し、撹拌しなから該液中に0.0
60%リン酸水溶液365gを4分間で添加した。(C
a/P−1,66)このとき液の91(は最初12.3
から11.2まで低下し、さらにこの液を7日間静置し
たところp)Iは8.0まで低下した。その結果沈澱物
は全くなく、ヒドロゾルが生成した。
Example 1 1.0 g of purified gelatin was dissolved in 500 g of 0.055% calcium hydroxide aqueous solution, and 0.0 g of purified gelatin was dissolved in the solution without stirring.
365 g of 60% phosphoric acid aqueous solution was added over 4 minutes. (C
a/P-1,66) At this time, the liquid 91 (was initially 12.3
When this liquid was allowed to stand still for 7 days, p)I decreased to 8.0. As a result, a hydrosol was produced without any precipitate.

このヒドロゾルを一部抜き取り、これに凝集剤である硫
酸ナトリウムを添加して凝集させ濾取した。得られたス
ラリーを風乾後に粉末X線回折を行ったところ、第1図
に示すように低結晶性のヒドロキシアパタイトであった
A portion of this hydrosol was taken out, and sodium sulfate as a flocculant was added thereto to flocculate it, which was then filtered. When the resulting slurry was air-dried and subjected to powder X-ray diffraction, it was found to be hydroxyapatite with low crystallinity as shown in FIG.

基体としてN25III11、横25mm、深さll1
11の凹部を有する縦40II111横40III11
1厚さ5a++wのアルミナ緻密焼結体(純度99.9
%)の凹部内に直径1m11のアルミナビーズが一層接
合されたものを準備した。
Base: N25III11, width 25mm, depth ll1
Vertical 40 II 111 horizontal 40 III 11 with 11 recesses
1 Alumina dense sintered body with a thickness of 5a++w (purity 99.9
%) was prepared in which alumina beads having a diameter of 1 m11 were bonded in a layer in a recess.

基体の凹部内が完全に満たされるまで上記のヒドロゾル
を注入後、風乾し焼成した。焼成条件として室温から8
00°Cまで100°C/Hrで昇温し、800°Cで
1時間の保持をした。
The above-mentioned hydrosol was injected until the inside of the recessed part of the base body was completely filled, and then air-dried and fired. The firing conditions range from room temperature to 8
The temperature was raised to 00°C at a rate of 100°C/Hr and held at 800°C for 1 hour.

焼成後の皮膜は光沢があり、干渉縞があった。The film after firing was shiny and had interference fringes.

皮膜の厚さを膜厚計にて測定した結果、その厚さは約0
.3μmであった。
As a result of measuring the thickness of the film with a film thickness meter, the thickness was approximately 0.
.. It was 3 μm.

得られた基体を生理食塩水に1週間浸漬したが、皮膜は
何ら変化せず強固であった。
The obtained substrate was immersed in physiological saline for one week, but the film remained strong without any change.

実施例2 0.060%リン酸水溶液405gを使用する以外は実
施例1と同様の試薬を用い同様の方法にてCa/P =
1.50のヒドロゾルを調製した。調製時のpHは最初
12.3から10.8まで低下し、さらにこの液を7日
間静置したところpuは8.0まで低下した。その結果
沈澱物は全くなく、ヒドロゾルが生成した。
Example 2 Ca/P = Ca/P =
A hydrosol of 1.50 was prepared. The pH at the time of preparation initially decreased from 12.3 to 10.8, and when this solution was allowed to stand for 7 days, the pu decreased to 8.0. As a result, a hydrosol was produced without any precipitate.

このヒドロゾルを実施例1と同様の方法で確認したとこ
ろ、低結晶性のヒドロキシアパタイトであった。
When this hydrosol was confirmed in the same manner as in Example 1, it was found to be hydroxyapatite with low crystallinity.

基体として表面粗さRa=0.05μmのアルミナ基板
(純度99.9%、縦10mm、横10mm、厚さ0.
hm)をアセトンで洗浄したものを準備した。
The base material was an alumina substrate with surface roughness Ra = 0.05 μm (purity 99.9%, length 10 mm, width 10 mm, thickness 0.
hm) washed with acetone was prepared.

このアルミナ基板の表面に上記のヒドロゾルを滴下して
厚さ111Imの液膜を形成した。その後、実施例1と
同様の方法、条件で風乾、焼成した。
The above hydrosol was dropped onto the surface of this alumina substrate to form a liquid film with a thickness of 111 Im. Thereafter, it was air-dried and fired in the same manner and under the same conditions as in Example 1.

焼成後の皮膜は実施例工と同様に光沢があり、干渉縞が
あった。
The film after firing was glossy and had interference fringes, similar to the example work.

皮膜の厚さを膜厚計にて測定した結果、その厚さは約0
.3μmであった。
As a result of measuring the thickness of the film with a film thickness meter, the thickness was approximately 0.
.. It was 3 μm.

得られた基体を実施例1と同様に生理食塩水に1週間浸
漬したが、皮膜は何ら変化せず強固であった。
The obtained substrate was immersed in physiological saline for one week in the same manner as in Example 1, but the film remained strong without any change.

実施例3 実施例1と同様のヒドロゾル並びにアルミナ緻密焼結体
を用い、実施例1と同様に該焼結体の凹部内にヒドロゾ
ルを注入し風乾した。
Example 3 Using the same hydrosol and alumina dense sintered body as in Example 1, the hydrosol was injected into the recesses of the sintered body and air-dried in the same manner as in Example 1.

引続き該焼結体を5%グルタルアルデヒド溶液に20時
間浸漬して不溶化処理した。
Subsequently, the sintered body was immersed in a 5% glutaraldehyde solution for 20 hours to be insolubilized.

該焼結体を実施例1と同様に生理食塩水に1週間浸漬し
たが、皮膜は何ら変化せず強固であった。
The sintered body was immersed in physiological saline for one week in the same manner as in Example 1, but the film remained strong without any change.

実施例4 基体として表面粗さRa= 0.2μmのチタン板(J
I52種、縦1011111、横10mm、厚さ1mm
)をアセトンで洗浄したものを準備した。
Example 4 A titanium plate (J
Type I52, length 1011111, width 10mm, thickness 1mm
) was prepared by washing it with acetone.

該チタン板の表面に実施例1で用いたヒドロゾルを滴下
して厚さ11の液膜を形成した。その後実施例1と同様
の方法、条件で風乾し焼成した。
The hydrosol used in Example 1 was dropped onto the surface of the titanium plate to form a liquid film with a thickness of 11 mm. Thereafter, it was air-dried and fired in the same manner and under the same conditions as in Example 1.

焼成後の皮膜は実施例1と同様に光沢があり、干渉縞が
あった。
The film after firing was glossy and had interference fringes as in Example 1.

皮膜の厚さを膜厚計にて測定した結果、その厚さは約0
.3μmであった。
As a result of measuring the thickness of the film with a film thickness meter, the thickness was approximately 0.
.. It was 3 μm.

得られたチタン板を実施例1と同様に生理食塩水に1週
間浸漬したが、皮膜は何ら変化せず強固であった。
The obtained titanium plate was immersed in physiological saline for one week in the same manner as in Example 1, but the film remained strong without any change.

比較例1 第ニリン酸アンモニウム水溶液と硝酸カルシウム水?g
Wlを混合し調整したヒドロキシアパタイト(未焼成品
)0.50gを0.1%ゼラチン水溶液1000gに添
加し撹拌したところ、1日後に全て沈澱した。これを再
び撹拌し懸濁物を実施例1と同様のアルミナ緻密焼結体
の凹部内に充填し、風乾した結果、白色の皮膜が形成し
た。引き続き実施例1と同様の焼成条件にて焼成したが
、得られた皮膜は触れると容易に剥離した。
Comparative Example 1 Ammonium diphosphate aqueous solution and calcium nitrate water? g
When 0.50 g of hydroxyapatite (unfired product) prepared by mixing Wl was added to 1000 g of a 0.1% gelatin aqueous solution and stirred, all of the mixture precipitated after one day. This was stirred again and the suspension was filled into the recesses of the same dense alumina sintered body as in Example 1, and air-dried to form a white film. Subsequently, the film was fired under the same firing conditions as in Example 1, but the resulting film peeled off easily when touched.

比較例2 ゼラチン存在下でない以外は実施例1と同じ濃度および
量の水酸化カルシウム水溶液、リン酸水溶液を混合した
ところpHの変化は同様であったが、混合直後に沈澱が
生成しヒドロゾルの形成はなかった。
Comparative Example 2 When a calcium hydroxide aqueous solution and a phosphoric acid aqueous solution were mixed in the same concentration and amount as in Example 1 except that they were not in the presence of gelatin, the change in pH was the same, but immediately after mixing, a precipitate was formed and a hydrosol was formed. There was no.

得られた沈澱を濾取し風乾後に粉末X線回折を行ったが
、第1図と全く同様のパターンを示し、低結晶性のヒド
ロキシアパタイトであることが判った。
The obtained precipitate was collected by filtration, air-dried, and subjected to powder X-ray diffraction, which showed a pattern exactly similar to that shown in FIG. 1, indicating that it was hydroxyapatite with low crystallinity.

基体として実施例1で使用したアルミナ緻密焼結体を用
い、該焼結体の凹部内に上記沈澱物を充填した後、実施
例1と同様の方法、条件で風乾し、焼成した。
The alumina dense sintered body used in Example 1 was used as a base, and the precipitate was filled into the recesses of the sintered body, and then air-dried and fired in the same manner and under the same conditions as in Example 1.

得られた皮膜は触れると容易に剥離した。The resulting film peeled off easily when touched.

比較例3 0.060%リン酸水溶液434gを使用した以外は実
施例1と同じものを使用し、同様の方法にてCa/P−
1,40のヒドロゾルを調整した。このヒドロゾルの一
部を取り凝集剤である硫酸ナトリうムを添加して凝集さ
せ濾取した。得られたスラリーを風乾後に実施例1と同
様に粉末X線回折を行った結果、低結晶性のヒドロキシ
アパタイトと第ニリン酸カルシウムの混合物であった。
Comparative Example 3 The same material as Example 1 was used except that 434 g of 0.060% phosphoric acid aqueous solution was used, and Ca/P-
A hydrosol of 1,40 was prepared. A portion of this hydrosol was collected by adding sodium sulfate as a flocculant to flocculate it and filtering it out. After air-drying the obtained slurry, powder X-ray diffraction was performed in the same manner as in Example 1, and the result showed that it was a mixture of low-crystalline hydroxyapatite and calcium diphosphate.

比較例4 0.060%リン酸水溶液243gを使用した以外は実
施例1と同じものを使用し、同様の方法にてCa/P=
2.50のヒドロゾルを調製した。このヒドロゾルの一
部を取り凝集剤である硫酸ナトリウムを添加して凝集さ
せ濾取した。得られたスラリーを風乾後に実施例1と同
様に粉末X線回折を行った結果、低結晶性のヒドロキシ
アパタイトと低結晶性の水酸化カルシウムの混合物であ
った。
Comparative Example 4 The same material as Example 1 was used except that 243 g of 0.060% phosphoric acid aqueous solution was used, and Ca/P=
A hydrosol of 2.50% was prepared. A portion of this hydrosol was collected by adding sodium sulfate as a flocculant to flocculate it and filtering it out. After air-drying the obtained slurry, powder X-ray diffraction was performed in the same manner as in Example 1, and the result showed that it was a mixture of low-crystalline hydroxyapatite and low-crystalline calcium hydroxide.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明によって得られたヒドロゾルを凝集させ
て濾取し、風乾した後の粉末X線回折図を示す。 手続補正書(自発) 1、 事件の表示 昭和62年 特許願第327727号 2、 発明の名称 ヒドロキシアパタイト皮膜の形成方法 3、補正をする者 事件との関係   特許出願人 住 所  大阪市東区北浜5丁目15番地名 称  (
209)住友化学工業株式会社代表者    森  英
 雄 4、代理人 住 所  大阪市東区北浜5丁目15番地5、補正の対
象 明細書の「発明の詳細な説明」の欄 6、 補正の内容 (1)  明細書第3頁第7行の’0.16m以上であ
る」を「0,5μmを超えている」と補正する。 (2)明細書第5頁第12行の「できながった。」を「
困難であった。」と補正する。 以上
FIG. 1 shows a powder X-ray diffraction pattern after the hydrosol obtained according to the present invention was aggregated, filtered, and air-dried. Procedural amendment (voluntary) 1. Indication of the case 1988 Patent Application No. 327727 2. Name of the invention Method for forming a hydroxyapatite film 3. Person making the amendment Relationship to the case Patent applicant address 5 Kitahama, Higashi-ku, Osaka 15-chome name (
209) Sumitomo Chemical Co., Ltd. Representative: Hideo Mori 4, Agent address: 5-15-5 Kitahama, Higashi-ku, Osaka City, “Detailed description of the invention” column 6 of the specification subject to the amendment, Contents of the amendment (1) ) In the 7th line of page 3 of the specification, ``It is 0.16 m or more'' is corrected to ``It is more than 0.5 μm.'' (2) Change “Done” on page 5, line 12 of the specification to “
It was difficult. ” he corrected. that's all

Claims (1)

【特許請求の範囲】[Claims] 保護コロイドの存在下に水酸化カルシウム水溶液とリン
酸水溶液をCa/P=1.50〜2.0(原子比)の割
合で混合し調整したヒドロゾルを基体に被覆した後、乾
燥し不溶化処理することを特徴とするヒドロキシアパタ
イト皮膜の形成方法
A substrate is coated with a hydrosol prepared by mixing an aqueous calcium hydroxide solution and an aqueous phosphoric acid solution at a ratio of Ca/P=1.50 to 2.0 (atomic ratio) in the presence of a protective colloid, and then dried and insolubilized. A method for forming a hydroxyapatite film characterized by
JP62327727A 1987-12-23 1987-12-23 Method for forming hydroxyapatite film Expired - Fee Related JP2629761B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP62327727A JP2629761B2 (en) 1987-12-23 1987-12-23 Method for forming hydroxyapatite film
DE8888312265T DE3865421D1 (en) 1987-12-23 1988-12-22 COATING LIQUID CONTAINING HYDROXYAPATITE AND METHOD FOR PRODUCING A HYDROXYAPATITE COVER USING THE SAME.
EP88312265A EP0322250B1 (en) 1987-12-23 1988-12-22 Coating liquor containing hydroxyapatite and method for forming hydroxyapatite coating film using the same
US07/576,166 US5030474A (en) 1987-12-23 1990-08-31 Method for forming hydroxyapatite coating film using coating liquor containing hydroxyapatite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62327727A JP2629761B2 (en) 1987-12-23 1987-12-23 Method for forming hydroxyapatite film

Publications (2)

Publication Number Publication Date
JPH01168872A true JPH01168872A (en) 1989-07-04
JP2629761B2 JP2629761B2 (en) 1997-07-16

Family

ID=18202311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62327727A Expired - Fee Related JP2629761B2 (en) 1987-12-23 1987-12-23 Method for forming hydroxyapatite film

Country Status (1)

Country Link
JP (1) JP2629761B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005193231A (en) * 2003-12-09 2005-07-21 Fujitsu Ltd Apatite coating film having photocatalystic activity and production method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62221359A (en) * 1986-03-24 1987-09-29 ペルメレツク電極株式会社 Titanium composite material coated with calcium phosphate and its production
JPS62252307A (en) * 1986-04-25 1987-11-04 Sekisui Plastics Co Ltd Wet synthesis of hydroxy apatite

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62221359A (en) * 1986-03-24 1987-09-29 ペルメレツク電極株式会社 Titanium composite material coated with calcium phosphate and its production
JPS62252307A (en) * 1986-04-25 1987-11-04 Sekisui Plastics Co Ltd Wet synthesis of hydroxy apatite

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005193231A (en) * 2003-12-09 2005-07-21 Fujitsu Ltd Apatite coating film having photocatalystic activity and production method thereof
JP4586170B2 (en) * 2003-12-09 2010-11-24 富士通株式会社 Apatite-containing film having photocatalytic activity and method for producing the same
US7939187B2 (en) 2003-12-09 2011-05-10 Fujitsu Limited Apatite-containing film having photocatalytic activity and a process for producing it
US7989258B2 (en) 2003-12-09 2011-08-02 Fujitsu Limited Apatite-containing film having photocatalytic activity and a process for producing it

Also Published As

Publication number Publication date
JP2629761B2 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
EP0437975B1 (en) Method for forming hydroxyapatite coating film
US5030474A (en) Method for forming hydroxyapatite coating film using coating liquor containing hydroxyapatite
US5141576A (en) Titanium composite materials coated with calcium phosphate compound and process for production thereof
Ferraz et al. Hydroxyapatite nanoparticles: a review of preparation methodologies
Coreno et al. Evaluation of calcium titanate as apatite growth promoter
US7998219B2 (en) Hydroxyapatite with controllable size and morphology
Wu et al. Low‐temperature preparation of anatase and rutile layers on titanium substrates and their ability to induce in vitro apatite deposition
US20020018903A1 (en) Anti-thrombogenic material and manufacturing method therefor
US5258044A (en) Electrophoretic deposition of calcium phosphate material on implants
Pasinli et al. A new approach in biomimetic synthesis of calcium phosphate coatings using lactic acid–Na lactate buffered body fluid solution
RU2630055C2 (en) Biocompatible component
Saleh et al. Biodegradable/biocompatible coated metal implants for orthopedic applications
JP2013508262A (en) Hydroxyapatite with controllable size and morphology
WO2003039609A1 (en) Deposition of coatings on substrates
JPS62204760A (en) Metal implant piece treated with ceramics
US4794023A (en) Process for producing a calcium phosphate compound coated composite material
WO1998013539A1 (en) Method for coating a calcium phosphate compound onto a metallic material
JP2006151729A (en) Composite material introduced with calcium phosphate layer and its manufacturing method
JPH01168872A (en) Formation of hydroxyapatite coating film
KR20090074190A (en) A titanium implant and a process for the preparation thereof
Chen et al. Phase transformation and morphology of calcium phosphate prepared by electrochemical deposition process through alkali treatment and calcination
CN106591923A (en) Preparation method of beta-tricalcium phosphate nanometer coating
JP4606813B2 (en) Calcium phosphate complex, method for producing the same, and artificial biomaterial using the same.
JP2004123484A (en) Metal oxide film and its use
JPH11323570A (en) Method of forming hydroxyapatite film

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees